Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Vor Biopharma Inc. Banner

Vor Biopharma Inc.

VOR Stock Analysis

Page title

Section title

Breakdown
2018
2019
2020
2021
2022
2023
Net Income
-4.152m-10.839m-43.337m-68.899m-92.094m-117.863m
Depreciation & Amortization
20.000K91.000K605.000K1.434M2.525M3.492M
Change in Working Capital
63.000K145.000K4.316M-9.185m-12.693m650.000K
Operating Cash Flow
-2.661m-9.855m-36.292m-69.144m-85.144m-100.292m
Capital Expenditure
0.000-748.000k-4.161m-3.894m-8.462m-1.069m
Free Cash Flow
-2.661m-10.603m-40.453m-73.038m-93.606m-101.361m
Debt Repayment
-2.464m0.0000.0000.0000.0000.000
Dividends Paid
0.0000.0000.0000.0000.0000.000
Common Stock Issued
0.00017.699M82.267M232.911M115.975M4.125M
Common Stock Repurchased
0.0000.0000.0000.0000.000-1.187m
Net Change in Cash
-197.000k7.096M42.073M72.116M-62.095m-26.346m